Patient Access to Urgent-Use Pharmacy Compounding Act of 2023

HR 167 allows pharmacies to compound drugs for urgent hospital use without a specific patient prescription under strict conditions. It requires hospitals to certify they couldn’t obtain FDA-approved or outsourcing-facility alternatives for the same active ingredient and route of administration. Compounded drugs must be labeled with a beyond-use date, marked for urgent use only, and hospitals must track patient administration within 7 days while reporting adverse events to the FDA within 15 days. This directly affects hospitals, pharmacists, and physicians during drug shortages, enabling faster access to necessary medications while maintaining safety and tracking requirements.